{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:01:05Z","timestamp":1787029265765,"version":"build-2736575974"},"reference-count":55,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Unione Europea-Next generation EU, \u201cMUR fondo promozione e sviluppo-DM737\/2001, INVIRCuM and PROCARAPINE\u201d, (University of Camerino, FAR 2022, PNR)"},{"name":"PRIN2022 Prot. 20223ABZ82 (MUR)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: D4R antagonists have recently been suggested as potential therapeutic alternatives to the standard treatments of glioblastoma (GBM). In this study, new piperidine-based ligands, analogs of the potent and selective D4R compounds 77-LH-28-1 (7) and its 4-benzyl analog 8, were synthesized and studied to investigate the effects produced by variations in the distances between the pharmacophoric features on the D4R affinity and selectivity. Methods: All the new compounds 9\u201320 were evaluated for their radioligand binding affinity at D2-like receptor subtypes and the results were rationalized by docking studies and molecular dynamics (MD) simulations. The functional profiles of the most interesting derivatives were assessed at D4R Go and Gi protein and \u03b2-arrestin by BRET assay and their potential anticancer activity was determined in GBM cell lines. Results: Radioligand binding results highlighted that the derivatives bearing a terminal butyl chain showed structure\u2013activity relationships different from those with a benzyl terminal. From functional studies performed on the best derivatives 12 and 16, the response profiles of both compounds were more robust in antagonist mode, with derivative 16 showing higher antagonist potency than 12 across all three transducers. Interestingly, 12 and 16 dose-dependently decreased the cell viability of GBM cells, inducing cell death and cell cycle arrest, promoting an increase in ROS production, causing mitochondrial dysfunction, and significantly inhibiting colony formation. Conclusions: The promising biological profiles of 12 and 16 make them new lead candidates that warrant further investigation to gain a better understanding of the mechanism behind their antitumor activity and better evaluate their potential for GBM treatment.<\/jats:p>","DOI":"10.3390\/ph18050739","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:54:28Z","timestamp":1747724068000},"page":"739","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8441-1794","authenticated-orcid":false,"given":"Federica","family":"Matteucci","sequence":"first","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1467-5792","authenticated-orcid":false,"given":"Pegi","family":"Pavleti\u0107","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"},{"name":"Faculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7306-0114","authenticated-orcid":false,"given":"Alessandro","family":"Bonifazi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rian","family":"Garland","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouv\u00e9 College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-3884","authenticated-orcid":false,"given":"Hideaki","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouv\u00e9 College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8711-9941","authenticated-orcid":false,"given":"Consuelo","family":"Amantini","sequence":"additional","affiliation":[{"name":"Immunopathology and Molecular Medicine Unit, School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6196-9673","authenticated-orcid":false,"given":"Laura","family":"Zeppa","sequence":"additional","affiliation":[{"name":"Immunopathology and Molecular Medicine Unit, School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-1894","authenticated-orcid":false,"given":"Emanuela","family":"Sabato","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-5172","authenticated-orcid":false,"given":"Giulio","family":"Vistoli","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Mammoli","sequence":"additional","affiliation":[{"name":"Center for Drug Discovery and Development-IDD, Aptuit, an Evotec Company, 37135 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8155-7211","authenticated-orcid":false,"given":"Loredana","family":"Cappellacci","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6538-6029","authenticated-orcid":false,"given":"Fabio","family":"Del Bello","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9576-6580","authenticated-orcid":false,"given":"Gianfabio","family":"Giorgioni","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-1204","authenticated-orcid":false,"given":"Riccardo","family":"Petrelli","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7885-0003","authenticated-orcid":false,"given":"Alessia","family":"Piergentili","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Quaglia","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-6826","authenticated-orcid":false,"given":"Alessandro","family":"Piergentili","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Xin, J., Fan, T., Guo, P., and Wang, J. (2019). Identification of functional divergence sites in dopamine receptors of vertebrates. Comput. Biol. Chem., 83.","DOI":"10.1016\/j.compbiolchem.2019.107140"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors\u2014IUPHAR Review 13","volume":"172","author":"Beaulieu","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0149-7634(99)00063-9","article-title":"Structure and function of dopamine receptors","volume":"24","author":"Vallone","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1054-3589(08)60786-3","article-title":"Signal transduction pathways modulated by D2-like dopamine receptors","volume":"42","author":"Huff","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113141","DOI":"10.1016\/j.ejmech.2020.113141","article-title":"Recent findings leading to the discovery of selective dopamine D(4) receptor ligands for the treatment of widespread diseases","volume":"212","author":"Giorgioni","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Botticelli, L., Micioni Di Bonaventura, E., Del Bello, F., Giorgioni, G., Piergentili, A., Romano, A., Quaglia, W., Cifani, C., and Micioni Di Bonaventura, M.V. (2020). Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors. Nutrients, 12.","DOI":"10.3390\/nu12082288"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12141","DOI":"10.1021\/acs.jmedchem.3c00734","article-title":"Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder","volume":"66","author":"Boateng","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1021\/acs.jmedchem.7b00151","article-title":"Return of D(4) Dopamine Receptor Antagonists in Drug Discovery","volume":"60","author":"Lindsley","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1471-4159.1995.65031157.x","article-title":"Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants","volume":"65","author":"Asghari","year":"1995","journal-title":"J. Neurochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-8993(96)01422-9","article-title":"Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera","volume":"752","author":"Ariano","year":"1997","journal-title":"Brain Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","article-title":"Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells","volume":"29","author":"Dolma","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12124","DOI":"10.1021\/acs.jmedchem.2c00840","article-title":"Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma","volume":"65","author":"Semeano","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"Pr123","DOI":"10.1021\/cr300113a","article-title":"Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders","volume":"113","author":"Ye","year":"2013","journal-title":"Chem. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.aan5468","article-title":"D(4) dopamine receptor high-resolution structures enable the discovery of selective agonists","volume":"358","author":"Wang","year":"2017","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e48822","DOI":"10.7554\/eLife.48822","article-title":"Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870","volume":"8","author":"Zhou","year":"2019","journal-title":"eLife"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1021\/acs.jmedchem.3c00537","article-title":"Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists","volume":"66","author":"Bock","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Levoin, N., Murthy, A.V.R., Narendar, V., Kumar, N.S., Aparna, P., Bhavani, A.K.D., Reddy, C.R., Mosset, P., and Gr\u00e9e, R. (2022). Discovery of potent dual ligands for dopamine D4 and \u03c31 receptors. Bioorganic Med. Chem., 69.","DOI":"10.1016\/j.bmc.2022.116851"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tolentino, K.T., Mashinson, V., Vadukoot, A.K., and Hopkins, C.R. (2022). Discovery and characterization of benzyloxy piperidine based dopamine 4 receptor antagonists. Bioorganic Med. Chem. Lett., 61.","DOI":"10.1016\/j.bmcl.2022.128615"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/acs.jmedchem.8b00265","article-title":"1-[3-(4-Butylpiperidin-1-yl) propyl]-1, 2, 3, 4-tetrahydroquinolin-2-one (77-LH-28-1) as a model for the rational design of a novel class of brain penetrant ligands with high affinity and selectivity for dopamine D4 receptor","volume":"61","author":"Bonifazi","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1021\/ja00323a035","article-title":".alpha.-Amino carbanions via formamidines. Alkylation of pyrrolidines, piperidines, and related heterocycles","volume":"106","author":"Meyers","year":"1984","journal-title":"J. Am. Chem. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"46170","DOI":"10.1039\/C6RA03841G","article-title":"Synthesis, biological evaluation and molecular modeling studies of phthalazin-1(2H)-one derivatives as novel cholinesterase inhibitors","volume":"6","author":"Vila","year":"2016","journal-title":"RSC Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/jm00042a007","article-title":"Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp","volume":"37","author":"Egbertson","year":"1994","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1021\/jm001088u","article-title":"Design, Synthesis, and Structure\u2013Activity Relationships of a Series of 3-[2-(1-Benzylpiperidin-4-yl)ethylamino]pyridazine Derivatives as Acetylcholinesterase Inhibitors","volume":"44","author":"Contreras","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1021\/acschemneuro.1c00368","article-title":"Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D(3) Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders","volume":"12","author":"Bonifazi","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1021\/acschemneuro.8b00677","article-title":"Multitarget 1,4-Dioxane Compounds Combining Favorable D(2)-like and 5-HT(1A) Receptor Interactions with Potential for the Treatment of Parkinson\u2019s Disease or Schizophrenia","volume":"10","author":"Ambrosini","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41420-022-01207-x","article-title":"Drug toxicity assessment: Cell proliferation versus cell death","volume":"8","author":"Sazonova","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","article-title":"Diffuse Glioma Heterogeneity and Its Therapeutic Implications","volume":"11","author":"Nicholson","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2016.01.055","article-title":"Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK","volume":"374","author":"Zhao","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10637-019-00764-w","article-title":"Emodin induced necroptosis in the glioma cell line U251 via the TNF-\u03b1\/RIP1\/RIP3 pathway","volume":"38","author":"Zhou","year":"2020","journal-title":"Investig. New Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41420-022-00974-x","article-title":"N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells","volume":"8","author":"Pagano","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phymed.2018.09.220","article-title":"Isofuranodiene synergizes with temozolomide in inducing glioma cells death","volume":"52","author":"Brunetti","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12672-025-01891-y","article-title":"The promise of mitochondria in the treatment of glioblastoma: A brief review","volume":"16","author":"Liang","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbrc.2020.04.133","article-title":"Sodium butyrate opens mitochondrial permeability transition pore (MPTP) to induce a proton leak in induction of cell apoptosis","volume":"527","author":"Qin","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1595","DOI":"10.1002\/wsbm.1595","article-title":"Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells","volume":"15","author":"Begum","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/jphp.13354","article-title":"Berberine, a natural alkaloid sensitizes human hepatocarcinoma to ionizing radiation by blocking autophagy and cell cycle arrest resulting in senescence","volume":"72","author":"Ramesh","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuro.2023.07.001","article-title":"CDN1163, a SERCA activator, causes intracellular Ca(2+) leak, mitochondrial hyperpolarization and cell cycle arrest in mouse neuronal N2A cells","volume":"98","author":"Huang","year":"2023","journal-title":"Neurotoxicology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mani, S., Swargiary, G., and Singh, K.K. (2020). Natural Agents Targeting Mitochondria in Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21196992"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1021\/acs.jmedchem.4c03150","article-title":"New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma","volume":"68","author":"Matteucci","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1021\/acs.jmedchem.9b02100","article-title":"Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and\/or 6-Positions of the 1,4-Dioxane Nucleus","volume":"63","author":"Bonifazi","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/bioinformatics\/btaa774","article-title":"The VEGA suite of programs: An versatile platform for cheminformatics and drug design projects","volume":"37","author":"Pedretti","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-012-1667-x","article-title":"Optimization of parameters for semiempirical methods VI: More modifications to the NDDO approximations and re-optimization of parameters","volume":"19","author":"Stewart","year":"2013","journal-title":"J. Mol. Model."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein-ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: A web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward realistic biological membrane simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J. Comput. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","article-title":"Lipid21: Complex Lipid Membrane Simulations with AMBER","volume":"18","author":"Dickson","year":"2022","journal-title":"J. Chem. Theory Comput."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"114502","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J. Chem. Phys."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM web server: Resources for positioning of proteins in membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0301-0104(98)00214-6","article-title":"Constant temperature simulations using the Langevin equation with velocity Verlet integration","volume":"236","author":"Paterlini","year":"1998","journal-title":"Chem. Phys."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","article-title":"A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations","volume":"22","year":"2001","journal-title":"J. Comput. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/5\/739\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:34:29Z","timestamp":1760031269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/5\/739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ph18050739"],"URL":"https:\/\/doi.org\/10.3390\/ph18050739","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]}}}